Table 4.
Nasal congestion | Groups | |
---|---|---|
Azelastine (Group B) (n = 120) n (%) |
Fluticasone (Group A) (n = 120) n (%) |
|
0 | 4 (3.3) | 0 |
1 | 0 | 0 |
2 | 32 (26.7) | 30 (25) |
3 | 84 (70) | 90 (75) |
Nasal congestion | Groups | |
---|---|---|
Azelastine (Group B) (n = 120) n (%) |
Fluticasone (Group A) (n = 120) n (%) |
|
0 | 4 (3.3) | 0 |
1 | 0 | 0 |
2 | 32 (26.7) | 30 (25) |
3 | 84 (70) | 90 (75) |